Scan to get started on Sahi
Rethink Trading
A new age Broking platform with in-house Sahi charts, real-time AI intelligence, and flat ₹10 per order brokerage.
4.5 ★ | 23K+ Ratings | IFTA Startup of the year 2025 | 8M+ downloads
Built for single-screen high performance acrossOptions Buying
Options Buying
Options Buying
Introducing the new & improved Sahi Scalper 2.0
Analyse & execute on a multi-chart layout. Watch the Index and Option Charts, Call & Put, Option Chain, simultaneously without moving an eye from your P&L.
Seamless Options Trading with Powerful Tools
Stay nimble and execute faster than ever before – no matter the screen size.
Trade from Charts, at Sahi Speed
Sahi’s powerful charts are built in-house & give you full control over your trades. Manage risk, optimize entries and exits, and never miss a movement – all without leaving your chart.
Real-Time market intelligence with Sahi AI
Tracks trends, identifies breakouts, highlights the hottest stocks
Analyse, Trade Option Strategies With Confidence
Create strategies that work for you. More control, better results.
Personalized Trading:
Tailor Your Space and Strategy
Personalize your homepage layout to match your trading style. Set up your workspace the way you want it, with just the tools you need.
High Performance Trading
at Incredible Value
Pay only ₹10 per executed order.
Latest news
Thyrocare Reports Q2 Consolidated Net Profit Of ₹15.9 Crore And Revenue Of ₹270 Crore
Thyrocare recorded Q2 revenue of ₹270 crore compared to ₹217 crore YoY. Consolidated net profit fell to ₹15.9 crore from ₹48 crore YoY, driven by a sharp contraction in EBITDA margin to 16.36% from 32.95% YoY.
Vedanta Oil and Gas Reports Q2 Revenue of ₹2,486 Crore vs ₹2,510 Crore QoQ
Vedanta Oil and Gas posted Q2 FY27 revenue of ₹2,486 crore, registering a minor sequential dip from ₹2,510 crore in Q1 FY27 alongside a 7% year-on-year expansion. Strong operational control lifted quarterly EBITDA by 34% YoY to ₹1,393 crore, with net profit standing at ₹746 crore.
RPG Life Sciences Reports Q2 Standalone Net Profit Of ₹23.3 Crore Vs ₹36.9 Crore YoY
RPG Life Sciences recorded a Q2 standalone net profit of ₹23.3 crore, down from ₹36.9 crore YoY (~36.86% YoY drop), indicating short-term earnings pressure.
